Back to top
Pomahope 3 mg Capsule
Pomahope 3 mg Capsule

Pomahope 3 mg Capsule

Pomahope 3 mg Capsule Specification

  • Pacakaging (Quantity Per Box)
  • 10 capsules per blister pack
  • Salt Composition
  • Pomalidomide
  • Origin of Medicine
  • Allopathic
  • Drug Type
  • Capsule
  • Ingredients
  • Pomalidomide 3 mg
  • Physical Form
  • Capsule
  • Function
  • Used to treat certain types of cancers such as multiple myeloma
  • Recommended For
  • Patients with multiple myeloma or other specified cancers
  • Dosage
  • 3 mg
  • Dosage Guidelines
  • Take one capsule orally as directed by the physician generally once a day or as per medical prescription
  • Suitable For
  • Adults
  • Quantity
  • 1 blister pack with 10 capsules
  • Storage Instructions
  • Store in a cool dry place below 30C. Keep away from direct sunlight and moisture.
 
 

About Pomahope 3 mg Capsule



Pomahope 3 mg Capsule is a potent medication in capsule form containing Pomalidomide 3 mg, primarily intended for patients diagnosed with multiple myeloma or other specified types of cancers. This allopathic medicine is designed to be taken orally as per the recommended dosage of one capsule daily, as advised by a healthcare professional. Pomahope is formulated to effectively combat certain cancers like multiple myeloma. Each blister pack consists of 10 capsules, suitable for adult patients. To maintain its efficacy, store the capsules in a cool, dry place below 30C, away from direct sunlight and moisture.

FAQs of Pomahope 3 mg Capsule:


Q: What is the recommended dosage for Pomahope 3 mg Capsule?

A: The recommended dosage for Pomahope 3 mg Capsule is one capsule orally per day, typically following medical guidance.

Q: What is the primary function of Pomahope 3 mg Capsule?

A: Pomahope 3 mg Capsule is primarily used to treat specific types of cancers such as multiple myeloma.

Q: How many capsules are there in a blister pack of Pomahope 3 mg Capsule?

A: Each blister pack of Pomahope 3 mg Capsule contains 10 capsules for patient use.

Q: What is the salt composition of Pomahope 3 mg Capsule?

A: The salt composition of Pomahope 3 mg Capsule is Pomalidomide, present in a 3 mg dosage.

Q: Is Pomahope 3 mg Capsule suitable for all age groups?

A: Pomahope 3 mg Capsule is specifically suitable for adults and must be used as directed by a healthcare provider.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Lupride Depot 22.5 mg Injection

Lupride Depot 22.5 mg Injection

Salt Composition : Leuprolide Acetate

Pacakaging (Quantity Per Box) : One singleuse vial per box

Dosage : 22.5 mg

Dosage Guidelines : Administered once every three months as directed by a healthcare provider

Origin of Medicine : Allopathic (Synthetic Medicine)

Recommended For : Adults with conditions requiring hormonal therapy

Ramiven 150 mg Tablet

Ramiven 150 mg Tablet

Salt Composition : Ramipril

Pacakaging (Quantity Per Box) : 10 tablets per blister pack

Dosage : 150 mg per tablet

Dosage Guidelines : Take one tablet once daily or as prescribed by a healthcare professional

Origin of Medicine : Allopathic

Recommended For : Adults suffering from hypertension or cardiovascular issues

Irinores 100 mg Injection

Irinores 100 mg Injection

Salt Composition : Irinotecan Hydrochloride

Pacakaging (Quantity Per Box) : 1 vial per box

Dosage : 100 mg

Dosage Guidelines : Administered intravenously under the supervision of a healthcare professional

Origin of Medicine : Allopathic

Recommended For : Patients undergoing colorectal cancer treatment

Pempro 100 mg Injection

Pempro 100 mg Injection

Salt Composition : Pemetrexed

Pacakaging (Quantity Per Box) : 1 vial per box

Dosage : As prescribed by a healthcare professional

Dosage Guidelines : Administered intravenously under the supervision of a healthcare professional; dosage depends on body surface area and specific therapy plan

Origin of Medicine : Allopathic

Recommended For : Patients undergoing treatment for cancer